148 related articles for article (PubMed ID: 32898632)
1. Analysis of antibody self-interaction by bio-layer interferometry as tool to support lead candidate selection during preformulation and developability assessments.
Domnowski M; Hackner B; Neuber T; Jaehrling J; Frieß W
Int J Pharm; 2020 Nov; 589():119854. PubMed ID: 32898632
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Antibody Self-Interaction by Bio-Layer-Interferometry as a Tool for Early Stage Formulation Development.
Domnowski M; Jaehrling J; Frieß W
Pharm Res; 2020 Jan; 37(2):29. PubMed ID: 31915934
[TBL] [Abstract][Full Text] [Related]
3. High throughput detection of antibody self-interaction by bio-layer interferometry.
Sun T; Reid F; Liu Y; Cao Y; Estep P; Nauman C; Xu Y
MAbs; 2013; 5(6):838-41. PubMed ID: 23995620
[TBL] [Abstract][Full Text] [Related]
4. Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection.
Lavoisier A; Schlaeppi JM
MAbs; 2015; 7(1):77-83. PubMed ID: 25514497
[TBL] [Abstract][Full Text] [Related]
5. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
[TBL] [Abstract][Full Text] [Related]
6. An accelerated surface-mediated stress assay of antibody instability for developability studies.
Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P
MAbs; 2020; 12(1):1815995. PubMed ID: 32954930
[TBL] [Abstract][Full Text] [Related]
7. High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice.
Kelly RL; Sun T; Jain T; Caffry I; Yu Y; Cao Y; Lynaugh H; Brown M; Vásquez M; Wittrup KD; Xu Y
MAbs; 2015; 7(4):770-7. PubMed ID: 26047159
[TBL] [Abstract][Full Text] [Related]
8. Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions.
Wei Y; Qi W; Maglalang E; Pelegri-O'Day EM; Luong M; Razinkov V; Sloey C
Mol Pharm; 2023 Dec; 20(12):6420-6428. PubMed ID: 37906640
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.
Liu Y; Caffry I; Wu J; Geng SB; Jain T; Sun T; Reid F; Cao Y; Estep P; Yu Y; Vásquez M; Tessier PM; Xu Y
MAbs; 2014; 6(2):483-92. PubMed ID: 24492294
[TBL] [Abstract][Full Text] [Related]
10. Measuring Self-Association of Antibody Lead Candidates with Dynamic Light Scattering.
Dingfelder F; Henriksen A; Wahlund PO; Arosio P; Lorenzen N
Methods Mol Biol; 2022; 2313():241-258. PubMed ID: 34478142
[TBL] [Abstract][Full Text] [Related]
11. Predicting Antibody Developability Profiles Through Early Stage Discovery Screening.
Bailly M; Mieczkowski C; Juan V; Metwally E; Tomazela D; Baker J; Uchida M; Kofman E; Raoufi F; Motlagh S; Yu Y; Park J; Raghava S; Welsh J; Rauscher M; Raghunathan G; Hsieh M; Chen YL; Nguyen HT; Nguyen N; Cipriano D; Fayadat-Dilman L
MAbs; 2020; 12(1):1743053. PubMed ID: 32249670
[TBL] [Abstract][Full Text] [Related]
12. AF4 and PEG Precipitation as Predictive Assays for Antibody Self-Association.
Condado-Morales I; Sokolova V; Wahlund PO; Heding KE; Auclair S; Kingsbury JS; Arosio P; Lorenzen N
Mol Pharm; 2023 Feb; 20(2):1323-1330. PubMed ID: 36668814
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Method Approach to Assess the Self-Interaction Behavior of Infliximab.
Domnowski M; Maruno T; Enomoto K; Kummer F; Kulakova A; Harris P; Uchiyama S; Jaehrling J; Friess W
J Pharm Sci; 2021 May; 110(5):1979-1988. PubMed ID: 33556386
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
[TBL] [Abstract][Full Text] [Related]
15. In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions.
Tomar DS; Li L; Broulidakis MP; Luksha NG; Burns CT; Singh SK; Kumar S
MAbs; 2017 Apr; 9(3):476-489. PubMed ID: 28125318
[TBL] [Abstract][Full Text] [Related]
16. Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties.
Starr CG; Makowski EK; Wu L; Berg B; Kingsbury JS; Gokarn YR; Tessier PM
Mol Pharm; 2021 Jul; 18(7):2744-2753. PubMed ID: 34105965
[TBL] [Abstract][Full Text] [Related]
17. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
[TBL] [Abstract][Full Text] [Related]
18. Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry.
Sivaccumar JP; Leonardi A; Iaccarino E; Corvino G; Sanguigno L; Chambery A; Russo R; Valletta M; Latino D; Capasso D; Doti N; Ruvo M; Sandomenico A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804612
[TBL] [Abstract][Full Text] [Related]
19. Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.
Li L; Kumar S; Buck PM; Burns C; Lavoie J; Singh SK; Warne NW; Nichols P; Luksha N; Boardman D
Pharm Res; 2014 Nov; 31(11):3161-78. PubMed ID: 24906598
[TBL] [Abstract][Full Text] [Related]
20. A novel screening method to assess developability of antibody-like molecules.
Kohli N; Jain N; Geddie ML; Razlog M; Xu L; Lugovskoy AA
MAbs; 2015; 7(4):752-8. PubMed ID: 25961854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
